KEAP1 and ischemic stroke: Despite its critical role in oxidative stress, Keap-1 has limited therapeutic significance in acute disease models such as ischemic stroke, largely due to its bio-refractory properties and long half-life (e.g., 12.7 h in HepG-2 cells) [96,97].